Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer

被引：0
|
作者：
Jan Nyrop Jakobsen
Jens Benn Sørensen
机构：
[1] Finsencentre,Department of Oncology
[2] Rigshospitalet,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Non-small cell lung cancer; NSCLC; Biomarkers; Heterogeneity; Chemotherapy; EGFR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：289 / 299
页数：10
相关论文
共 50 条
  • [1] Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer
    Jakobsen, Jan Nyrop
    Sorensen, Jens Benn
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 289 - 299
  • [2] Intratumor heterogeneity of non-small-cell lung cancer with EGFR mutations
    Qiao, Sitan
    Zhao, Xin
    Zhou, Xinlan
    Zhang, Yaxiong
    Zhang, Li
    Wu, Kui
    CANCER RESEARCH, 2019, 79 (13)
  • [3] CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer
    Francescangeli, Federica
    De Angelis, Maria Laura
    Rossi, Rachele
    Sette, Giovanni
    Eramo, Adriana
    Boe, Alessandra
    Guardiola, Ombretta
    Tang, Tao
    Yu, Shi-Cang
    Minchiotti, Gabriella
    Zeuner, Ann
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Effect of chemotherapy on EGFR mutation status in Chinese non-small cell lung cancer patients
    Wang, J.
    Bai, H.
    Zhao, J.
    Wang, Z.
    Zhuo, W.
    Wu, M.
    Duan, J.
    Wang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Prevention and treatment of chemotherapy-induced nausea and vomiting in adults with non-small cell lung cancer
    Campos, Emilio
    Carlos Roldan-Morales, Jose
    Guerra-Estevez, Dulce
    Jose Ramos-Baez, Juan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 222 - 222
  • [6] CURRENT STATUS OF CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER
    AISNER, J
    HANSEN, HH
    CANCER TREATMENT REPORTS, 1981, 65 (11-1): : 979 - 986
  • [7] The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
    Nicos, Marcin
    Krawczyk, Pawel
    Crosetto, Nicola
    Milanowski, Janusz
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [8] Generation of Non-Small Cell Lung Cancer Patient-Derived Xenografts to Study Intratumor Heterogeneity
    Kanaki, Zoi
    Voutsina, Alexandra
    Markou, Athina
    Pateras, Ioannis S.
    Potaris, Konstantinos
    Avgeris, Margaritis
    Makrythanasis, Periklis
    Athanasiadis, Emmanouil I.
    Vamvakaris, Ioannis
    Patsea, Eleni
    Vachlas, Konstantinos
    Lianidou, Evi
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    Klinakis, Apostolos
    CANCERS, 2021, 13 (10)
  • [9] Intratumor heterogeneity in non-small cell lung cancer inferred by multi-region exome sequencing
    Bruin, Elza D.
    McGranahan, Nicholas
    Yates, Lucy
    Jamal-Hanjani, Mariam
    Salm, Max
    Mitter, Richard
    Shafi, Seema
    Murugaesu, Nirupa
    Rowan, Andrew
    Gerlinger, Marco
    Wedge, David
    Horswell, Stuart
    Varela, Ignacio
    Tom, Warren
    Parikh, Chaitali
    Harkins, Timothy
    Lee, Clarence
    Matthews, Nik
    Stewart, Aengus
    Campbell, Peter
    Swanton, Charles
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Chemotherapy influence EGFR mutation status for Chinese patients with regionally advanced non-small cell lung cancer
    Wang, J.
    Chen, K.
    Bai, H.
    Zhao, J.
    Wang, Z.
    Zhuo, M.
    An, T.
    Duan, J.
    Yang, L.
    Wu, M.
    Guo, Q.
    Liu, X.
    Wang, S.
    Wang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345